Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China flag China · Delayed Price · Currency is CNY
8.44
-0.25 (-2.88%)
May 21, 2026, 3:04 PM CST

SHE:300534 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
234.61241.33310.02288.95369.2499.12
Cash & Short-Term Investments
234.61241.33310.02288.95369.2499.12
Cash Growth
-14.64%-22.16%7.29%-21.75%272.52%-16.13%
Accounts Receivable
292.05257.51223.85223.8220.95140.44
Other Receivables
6.0611.0626.9919.519.75.53
Receivables
298.11268.57250.83243.3240.65145.98
Inventory
109.62115.99115.997.485.8755.7
Prepaid Expenses
-1.940.040.160.21.4
Other Current Assets
42.3126.4636.7417.1931.576.51
Total Current Assets
684.65654.3713.53647727.54308.7
Property, Plant & Equipment
527.21531.64519.78439.42333.85305.21
Long-Term Investments
52.7552.7551.3654.254.254.2
Goodwill
13.7213.7213.7213.7213.7213.72
Other Intangible Assets
67.8668.6563.0662.0762.2250.74
Long-Term Deferred Tax Assets
14.1314.1311.510.128.585.77
Long-Term Deferred Charges
6.45.681.660.230.14-
Other Long-Term Assets
53.753.6270.51109.89117.2585.73
Total Assets
1,4201,3941,4451,3371,318824.07
Accounts Payable
325.39319.44371.29243.56209.0132.63
Accrued Expenses
6.8719.1927.3923.1158.516.3
Short-Term Debt
-0.254.930.03--
Current Portion of Long-Term Debt
49.9325.0810.2---
Current Portion of Leases
-1.451.161.19--
Current Income Taxes Payable
17.237.6730.9121.117.481.78
Current Unearned Revenue
9.1415.6222.465.6577.2412.96
Other Current Liabilities
36.8769.0473.4453.745.0814.64
Total Current Liabilities
445.44457.74541.69438.34407.3268.32
Long-Term Debt
103.35103.3595.84109.6--
Long-Term Leases
2.172.382.583.72--
Long-Term Unearned Revenue
52.4646.940.0826.4426.8922.92
Long-Term Deferred Tax Liabilities
3.053.051.540.24-0
Other Long-Term Liabilities
--23.7546.8--
Total Liabilities
606.47613.42705.47625.14434.2191.24
Common Stock
303.35303.35303.35303.35303.35303.35
Additional Paid-In Capital
97.1597.1592.1566.68324231.49
Retained Earnings
333.67309.01277.19263.68202.03185.42
Comprehensive Income & Other
-1.05-1.05-2.24---
Total Common Equity
733.11708.45670.45633.71829.38720.25
Minority Interest
80.8472.6269.2177.853.9212.59
Shareholders' Equity
813.96781.08739.66711.51883.3732.84
Total Liabilities & Equity
1,4201,3941,4451,3371,318824.07
Total Debt
155.45132.51114.68144.54--
Net Cash (Debt)
79.16108.82195.34144.4369.2499.12
Net Cash Growth
-54.50%-44.29%35.27%-60.89%272.52%105.97%
Net Cash Per Share
0.260.360.640.481.220.33
Filing Date Shares Outstanding
303.34303.35303.35303.35303.35303.35
Total Common Shares Outstanding
303.34303.35303.35303.35303.35303.35
Working Capital
239.21196.56171.84208.65320.22240.38
Book Value Per Share
2.422.342.212.092.732.37
Tangible Book Value
651.53626.08593.66557.91753.43655.78
Tangible Book Value Per Share
2.152.061.961.842.482.16
Buildings
-524.52483.38339.21338.42283.91
Machinery
-240.33205.81148.61125.1466.35
Construction In Progress
-5.6427.61105.76.0937.76
Source: S&P Global Market Intelligence. Standard template. Financial Sources.